カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のジフテリア破傷風百日せきワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Diphtheria Tetanus Pertussis Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19266）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19266
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：105
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のジフテリア破傷風百日せきワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ジフテリア破傷風百日せきワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のジフテリア破傷風百日せきワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ジフテリア破傷風百日せきワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・DTwPタイプ、DTaPタイプ

用途別セグメントは次のように区分されます。
・子供、中高生、成人

世界のジフテリア破傷風百日せきワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi Pasteur、GSK、AJ Vaccines、KM Biologics (Meiji)、MCM Vaccine、Merck、MassBiologics、Bionet-Asia、Amson Vaccines & Pharma、Serum Institute of India、Panacea Biotec、BioKangtai、China National Biotec、Chengdu Oulin Biological Science&Technology

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ジフテリア破傷風百日せきワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なジフテリア破傷風百日せきワクチンメーカーの企業概要、2019年～2022年までのジフテリア破傷風百日せきワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なジフテリア破傷風百日せきワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ジフテリア破傷風百日せきワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのジフテリア破傷風百日せきワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのジフテリア破傷風百日せきワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびジフテリア破傷風百日せきワクチンの産業チェーンを掲載しています。
・第13、14、15章では、ジフテリア破傷風百日せきワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ジフテリア破傷風百日せきワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：DTwPタイプ、DTaPタイプ
- 用途別分析（2017年vs2021年vs2028年）：子供、中高生、成人
- 世界のジフテリア破傷風百日せきワクチン市場規模・予測
- 世界のジフテリア破傷風百日せきワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Sanofi Pasteur、GSK、AJ Vaccines、KM Biologics (Meiji)、MCM Vaccine、Merck、MassBiologics、Bionet-Asia、Amson Vaccines & Pharma、Serum Institute of India、Panacea Biotec、BioKangtai、China National Biotec、Chengdu Oulin Biological Science&Technology
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：DTwPタイプ、DTaPタイプ
・用途別分析2017年-2028年：子供、中高生、成人
・ジフテリア破傷風百日せきワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ジフテリア破傷風百日せきワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ジフテリア破傷風百日せきワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ジフテリア破傷風百日せきワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ジフテリア破傷風百日せきワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Diphtheria Tetanus Pertussis Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Diphtheria Tetanus Pertussis Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Child accounting for % of the Diphtheria Tetanus Pertussis Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DTwP Type segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Diphtheria Tetanus Pertussis Vaccine include Sanofi Pasteur, GSK, AJ Vaccines, KM Biologics (Meiji), and MCM Vaccine, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Diphtheria Tetanus Pertussis Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DTwP Type
DTaP Type
Market segment by Application can be divided into
Child
Teenager
Aldult
The key market players for global Diphtheria Tetanus Pertussis Vaccine market are listed below:
Sanofi Pasteur
GSK
AJ Vaccines
KM Biologics (Meiji)
MCM Vaccine
Merck
MassBiologics
Bionet-Asia
Amson Vaccines & Pharma
Serum Institute of India
Panacea Biotec
BioKangtai
China National Biotec
Chengdu Oulin Biological Science&Technology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diphtheria Tetanus Pertussis Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diphtheria Tetanus Pertussis Vaccine, with price, sales, revenue and global market share of Diphtheria Tetanus Pertussis Vaccine from 2019 to 2022.
Chapter 3, the Diphtheria Tetanus Pertussis Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diphtheria Tetanus Pertussis Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Diphtheria Tetanus Pertussis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diphtheria Tetanus Pertussis Vaccine.
Chapter 13, 14, and 15, to describe Diphtheria Tetanus Pertussis Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Diphtheria Tetanus Pertussis Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 DTwP Type
1.2.3 DTaP Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Child
1.3.3 Teenager
1.3.4 Aldult
1.4 Global Diphtheria Tetanus Pertussis Vaccine Market Size & Forecast
1.4.1 Global Diphtheria Tetanus Pertussis Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Diphtheria Tetanus Pertussis Vaccine Sales in Volume (2017-2028)
1.4.3 Global Diphtheria Tetanus Pertussis Vaccine Price (2017-2028)
1.5 Global Diphtheria Tetanus Pertussis Vaccine Production Capacity Analysis
1.5.1 Global Diphtheria Tetanus Pertussis Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Diphtheria Tetanus Pertussis Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diphtheria Tetanus Pertussis Vaccine Market Drivers
1.6.2 Diphtheria Tetanus Pertussis Vaccine Market Restraints
1.6.3 Diphtheria Tetanus Pertussis Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product and Services
2.1.4 Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Diphtheria Tetanus Pertussis Vaccine Product and Services
2.2.4 GSK Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AJ Vaccines
2.3.1 AJ Vaccines Details
2.3.2 AJ Vaccines Major Business
2.3.3 AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Product and Services
2.3.4 AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 KM Biologics (Meiji)
2.4.1 KM Biologics (Meiji) Details
2.4.2 KM Biologics (Meiji) Major Business
2.4.3 KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Product and Services
2.4.4 KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 MCM Vaccine
2.5.1 MCM Vaccine Details
2.5.2 MCM Vaccine Major Business
2.5.3 MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Product and Services
2.5.4 MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Diphtheria Tetanus Pertussis Vaccine Product and Services
2.6.4 Merck Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 MassBiologics
2.7.1 MassBiologics Details
2.7.2 MassBiologics Major Business
2.7.3 MassBiologics Diphtheria Tetanus Pertussis Vaccine Product and Services
2.7.4 MassBiologics Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bionet-Asia
2.8.1 Bionet-Asia Details
2.8.2 Bionet-Asia Major Business
2.8.3 Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Product and Services
2.8.4 Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amson Vaccines & Pharma
2.9.1 Amson Vaccines & Pharma Details
2.9.2 Amson Vaccines & Pharma Major Business
2.9.3 Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Product and Services
2.9.4 Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Serum Institute of India
2.10.1 Serum Institute of India Details
2.10.2 Serum Institute of India Major Business
2.10.3 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product and Services
2.10.4 Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Panacea Biotec
2.11.1 Panacea Biotec Details
2.11.2 Panacea Biotec Major Business
2.11.3 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Product and Services
2.11.4 Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 BioKangtai
2.12.1 BioKangtai Details
2.12.2 BioKangtai Major Business
2.12.3 BioKangtai Diphtheria Tetanus Pertussis Vaccine Product and Services
2.12.4 BioKangtai Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 China National Biotec
2.13.1 China National Biotec Details
2.13.2 China National Biotec Major Business
2.13.3 China National Biotec Diphtheria Tetanus Pertussis Vaccine Product and Services
2.13.4 China National Biotec Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Chengdu Oulin Biological Science&Technology
2.14.1 Chengdu Oulin Biological Science&Technology Details
2.14.2 Chengdu Oulin Biological Science&Technology Major Business
2.14.3 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Product and Services
2.14.4 Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Diphtheria Tetanus Pertussis Vaccine Breakdown Data by Manufacturer
3.1 Global Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Diphtheria Tetanus Pertussis Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Diphtheria Tetanus Pertussis Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Diphtheria Tetanus Pertussis Vaccine Manufacturer Market Share in 2021
3.5 Global Diphtheria Tetanus Pertussis Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Diphtheria Tetanus Pertussis Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diphtheria Tetanus Pertussis Vaccine Market Size by Region
4.1.1 Global Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2017-2028)
4.2 North America Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028)
4.3 Europe Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028)
4.5 South America Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type (2017-2028)
5.3 Global Diphtheria Tetanus Pertussis Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application (2017-2028)
6.3 Global Diphtheria Tetanus Pertussis Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2028)
7.2 North America Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2028)
7.3 North America Diphtheria Tetanus Pertussis Vaccine Market Size by Country
7.3.1 North America Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2028)
8.2 Europe Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2028)
8.3 Europe Diphtheria Tetanus Pertussis Vaccine Market Size by Country
8.3.1 Europe Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Market Size by Region
9.3.1 Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2028)
10.2 South America Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2028)
10.3 South America Diphtheria Tetanus Pertussis Vaccine Market Size by Country
10.3.1 South America Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Market Size by Country
11.3.1 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Diphtheria Tetanus Pertussis Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Diphtheria Tetanus Pertussis Vaccine
12.3 Diphtheria Tetanus Pertussis Vaccine Production Process
12.4 Diphtheria Tetanus Pertussis Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Diphtheria Tetanus Pertussis Vaccine Typical Distributors
13.3 Diphtheria Tetanus Pertussis Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 6. Sanofi Pasteur Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 10. GSK Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AJ Vaccines Basic Information, Manufacturing Base and Competitors
Table 12. AJ Vaccines Major Business
Table 13. AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 14. AJ Vaccines Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. KM Biologics (Meiji) Basic Information, Manufacturing Base and Competitors
Table 16. KM Biologics (Meiji) Major Business
Table 17. KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 18. KM Biologics (Meiji) Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. MCM Vaccine Basic Information, Manufacturing Base and Competitors
Table 20. MCM Vaccine Major Business
Table 21. MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 22. MCM Vaccine Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 26. Merck Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. MassBiologics Basic Information, Manufacturing Base and Competitors
Table 28. MassBiologics Major Business
Table 29. MassBiologics Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 30. MassBiologics Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bionet-Asia Basic Information, Manufacturing Base and Competitors
Table 32. Bionet-Asia Major Business
Table 33. Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 34. Bionet-Asia Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Amson Vaccines & Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Amson Vaccines & Pharma Major Business
Table 37. Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 38. Amson Vaccines & Pharma Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 40. Serum Institute of India Major Business
Table 41. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 42. Serum Institute of India Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 44. Panacea Biotec Major Business
Table 45. Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 46. Panacea Biotec Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. BioKangtai Basic Information, Manufacturing Base and Competitors
Table 48. BioKangtai Major Business
Table 49. BioKangtai Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 50. BioKangtai Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 52. China National Biotec Major Business
Table 53. China National Biotec Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 54. China National Biotec Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Chengdu Oulin Biological Science&Technology Basic Information, Manufacturing Base and Competitors
Table 56. Chengdu Oulin Biological Science&Technology Major Business
Table 57. Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Product and Services
Table 58. Chengdu Oulin Biological Science&Technology Diphtheria Tetanus Pertussis Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Diphtheria Tetanus Pertussis Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Diphtheria Tetanus Pertussis Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Diphtheria Tetanus Pertussis Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Diphtheria Tetanus Pertussis Vaccine Production Site of Key Manufacturer
Table 64. Diphtheria Tetanus Pertussis Vaccine New Entrant and Capacity Expansion Plans
Table 65. Diphtheria Tetanus Pertussis Vaccine Mergers & Acquisitions in the Past Five Years
Table 66. Global Diphtheria Tetanus Pertussis Vaccine Sales by Region (2017-2022) & (K Units)
Table 67. Global Diphtheria Tetanus Pertussis Vaccine Sales by Region (2023-2028) & (K Units)
Table 68. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Global Diphtheria Tetanus Pertussis Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Diphtheria Tetanus Pertussis Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Diphtheria Tetanus Pertussis Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Global Diphtheria Tetanus Pertussis Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Diphtheria Tetanus Pertussis Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Diphtheria Tetanus Pertussis Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Diphtheria Tetanus Pertussis Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2017-2022) & (K Units)
Table 83. North America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2023-2028) & (K Units)
Table 84. North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2022) & (K Units)
Table 87. North America Diphtheria Tetanus Pertussis Vaccine Sales by Type (2023-2028) & (K Units)
Table 88. North America Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2022) & (K Units)
Table 89. North America Diphtheria Tetanus Pertussis Vaccine Sales by Application (2023-2028) & (K Units)
Table 90. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country (2017-2022) & (K Units)
Table 91. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Country (2023-2028) & (K Units)
Table 92. Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2022) & (K Units)
Table 95. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Type (2023-2028) & (K Units)
Table 96. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2022) & (K Units)
Table 97. Europe Diphtheria Tetanus Pertussis Vaccine Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales by Application (2023-2028) & (K Units)
Table 106. South America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2017-2022) & (K Units)
Table 107. South America Diphtheria Tetanus Pertussis Vaccine Sales by Country (2023-2028) & (K Units)
Table 108. South America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Diphtheria Tetanus Pertussis Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2022) & (K Units)
Table 111. South America Diphtheria Tetanus Pertussis Vaccine Sales by Type (2023-2028) & (K Units)
Table 112. South America Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2022) & (K Units)
Table 113. South America Diphtheria Tetanus Pertussis Vaccine Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales by Application (2023-2028) & (K Units)
Table 122. Diphtheria Tetanus Pertussis Vaccine Raw Material
Table 123. Key Manufacturers of Diphtheria Tetanus Pertussis Vaccine Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Diphtheria Tetanus Pertussis Vaccine Typical Distributors
Table 127. Diphtheria Tetanus Pertussis Vaccine Typical Customers
List of Figures
Figure 1. Diphtheria Tetanus Pertussis Vaccine Picture
Figure 2. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Type in 2021
Figure 3. DTwP Type
Figure 4. DTaP Type
Figure 5. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Application in 2021
Figure 6. Child
Figure 7. Teenager
Figure 8. Aldult
Figure 9. Global Diphtheria Tetanus Pertussis Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Diphtheria Tetanus Pertussis Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Diphtheria Tetanus Pertussis Vaccine Sales (2017-2028) & (K Units)
Figure 12. Global Diphtheria Tetanus Pertussis Vaccine Price (2017-2028) & (US$/Unit)
Figure 13. Global Diphtheria Tetanus Pertussis Vaccine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Diphtheria Tetanus Pertussis Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Diphtheria Tetanus Pertussis Vaccine Market Drivers
Figure 16. Diphtheria Tetanus Pertussis Vaccine Market Restraints
Figure 17. Diphtheria Tetanus Pertussis Vaccine Market Trends
Figure 18. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Diphtheria Tetanus Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Diphtheria Tetanus Pertussis Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Diphtheria Tetanus Pertussis Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Diphtheria Tetanus Pertussis Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Diphtheria Tetanus Pertussis Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Diphtheria Tetanus Pertussis Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Diphtheria Tetanus Pertussis Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Diphtheria Tetanus Pertussis Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Diphtheria Tetanus Pertussis Vaccine
Figure 78. Diphtheria Tetanus Pertussis Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ジフテリア/破傷風/百日咳（DPT）ワクチンのグローバル市場展望 2023年-2029年：DTwP型、DTaP型
  • 無細胞ジフテリア百日咳菌インフルエンザ菌B型混合ワクチンのグローバル市場展望 2023年-2029年：0.5mL用量、1.5mL用量
  • 破傷風ワクチンのグローバル市場展望 2023年-2029年：ジフテリア・破傷風（DT）ワクチン、ジフテリア・破傷風・百日咳（百日咳）（DTaP）ワクチン、破傷風・ジフテリア（Td）ワクチン、破傷風・ジフテリア・百日咳（Tdap）ワクチン
  • 世界のDTPワクチン市場2022年：市場規模予測（～2028年）
  • 世界の百日咳予防接種市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19266 )"世界のジフテリア破傷風百日せきワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Diphtheria Tetanus Pertussis Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。